Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$11.68 USD
+0.17 (1.48%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $11.70 +0.02 (0.17%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Alignment Healthcare, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -148.17 | -149.64 | -195.29 | -22.93 | -44.73 |
Depreciation/Amortization & Depletion | 18.01 | 19.34 | 18.29 | 17.65 | 18.53 |
Net Change from Assets/Liabilities | 2.03 | -5.55 | -19.42 | 3.25 | 29.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 68.96 | 90.43 | 117.64 | 9.58 | 6.41 |
Net Cash From Operating Activities | -59.19 | -45.43 | -78.78 | 7.56 | 9.21 |
Property & Equipment | -36.00 | -23.77 | -18.36 | -15.61 | -10.25 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -4.04 | -1.41 | 0.00 | 0.00 |
Investments | -111.27 | -0.40 | -1.05 | -0.75 | 0.01 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -147.26 | -28.22 | -20.82 | -16.36 | -10.24 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 389.13 | 133.50 | -1.48 |
Issuance (Repayment) of Debt | 0.00 | 21.82 | 0.00 | 0.00 | 55.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.11 | -5.23 | -29.00 | -3.37 | -0.85 |
Net Cash from Financing Activities | 0.11 | 16.59 | 360.13 | 130.12 | 52.67 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -206.35 | -57.05 | 260.54 | 121.33 | 51.63 |
Cash at Beginning of Period | 411.30 | 468.35 | 207.81 | 86.48 | 34.85 |
Cash at End of Period | 204.95 | 411.30 | 468.35 | 207.81 | 86.48 |
Diluted Net EPS | -0.79 | -0.83 | -1.14 | -36.92 | NA |
Fiscal Year End for Alignment Healthcare, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -70.58 | -46.58 | -148.17 | -100.94 | -65.87 |
Depreciation/Amortization & Depletion | 11.42 | 5.40 | 18.01 | 13.50 | 9.26 |
Net Change from Assets/Liabilities | 37.65 | 13.47 | 2.03 | 163.09 | 140.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 38.81 | 21.47 | 68.96 | 52.64 | 38.72 |
Net Cash From Operating Activities | 17.29 | -6.24 | -59.19 | 128.28 | 122.29 |
Property & Equipment | -22.85 | -11.12 | -36.00 | -25.40 | -15.85 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 92.52 | 53.83 | -111.27 | -120.85 | -120.79 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 69.67 | 42.71 | -147.26 | -146.25 | -136.64 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 50.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.85 | -0.34 | 0.11 | 0.06 | 0.06 |
Net Cash from Financing Activities | 49.15 | -0.34 | 0.11 | 0.06 | 0.06 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 136.12 | 36.13 | -206.35 | -17.91 | -14.29 |
Cash at Beginning of Period | 204.95 | 204.95 | 411.30 | 411.30 | 411.30 |
Cash at End of Period | 341.07 | 241.09 | 204.95 | 393.39 | 397.01 |
Diluted Net EPS | -0.13 | -0.25 | -0.25 | -0.19 | -0.15 |